Website & contact details
- Website
Lario Therapeutics Limited
- Incorporated
- 26 November 2021 (4 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Chiara Rossana Maria Liberati
- Owned by
- Accounts type
- Small
- Region
- Scotland
- Address
- 137A George StreetEdinburghEH2 4JY
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 9 December 2026
- Last conf. stmt
- 25 November 2025
Officers 3 active
Officer details are public data from the Companies House register.
Director · Appointed 9 July 2024
British
Born July 1967 (59)
Liberati, Chiara Rossana Maria, Dr
Director · Appointed 1 June 2023
Italian
Born September 1970 (56)
Director · Appointed 26 November 2021
German
Born November 1969
Officer history (2 former)
9 July 2024
9 July 2024
1 June 2023
Appointed Liberati, Chiara Rossana Maria, Dr as Director
1 June 2023
Resigned Lohmer, Stefan, Dr as Director
25 March 2022
Appointed Lohmer, Stefan, Dr as Director
25 March 2022
26 November 2021
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 28 March 2022
Owns 50–75% of shares
Holds 25–50% of voting rights
Scottish Limited Partnership
Reg. no. Sl033678
Former controllers (1)
25 March 2022
Group structure 26 shown
Ownership group derived from the Companies House PSC register
BBB Investment Holdings Limited Owns 75–100% of shares
BBB Investment Services Limited Owns 75–100% of shares
BBB Mandates Limited Owns 75–100% of shares
BGP General Partner I LLP Holds 75–100% of voting rights
British Business Access Lending Limited Owns 75–100% of shares
British Business Investments Ltd Owns 75–100% of shares
Federated Hermes Private Equity Innovation II LP Part right to 25–50% of surplus assets
Hermes Gpe Environmental Innovation Fund LP Part right to 25–50% of surplus assets
Hermes Gpe Innovation Fund LP Part right to 25–50% of surplus assets
UK FTF L.P. Holds 25–50% of voting rights
British Patient Capital Limited Owns 75–100% of shares
Epidarex Capital IV, LP Part right to 25–50% of surplus assets
Nations and Regions Investments Limited Owns 75–100% of shares
British Business Finance Ltd Owns 75–100% of shares
British Business Aspire Holdco Ltd Owns 75–100% of shares
Capital for Enterprise Fund L.P. Holds 50–75% of voting rights
Epidarex Capital Iii UK, LP Part right to 25–50% of surplus assets
Epidarex Exeed Limited Owns 75–100% of shares
Lario Therapeutics Limited This company Owns 50–75% of shares
Macomics Ltd Owns 25–50% of shares
Rinn Therapeutics Limited Owns 75–100% of shares
Passion Capital GC (FP) LLP Right to 50–75% of surplus assets
Pentech Fund Iii Limited Partnership Part right to 25–50% of surplus assets
The Start-Up Loans Company Right to appoint and remove directors
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Cash
- £1,364,922
- Current Ratio
- 0.2x
Balance sheet detail
| 2024 | |
|---|---|
| Current Assets | £1,507,895 |
| Debtors | £142,973 |
| Cash | £1,364,922 |
| Creditors (< 1 year) | £7,382,195 |
| Net Current Assets | (£5,874,300) |
| Shareholder Funds | (£4,786,797) |
What Lario Therapeutics say about themselves
“Lario Therapeutics are developing first-in-class disease modifying treatments for severe neurological disorders. Precision Neuroscience Today.”
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 23 October 2026 | Change of details for a person with significant control |
Some other companies at this address
Other companies in this industry
Cambridge
Cambridge
Abingdon
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →